Peptide questions · MK-677

MK-677 side effects: what studies and users report

Reviewed Evidence: ModeratePublished by PepVault

The side effects most commonly reported for MK-677 are increased appetite, water retention and lethargy, among 6 the library lists; the library’s evidence on it includes controlled trials in people.

The library holds no separate safety note for MK-677.

What is commonly reported with MK-677

  • Increased appetite
  • Water retention
  • Lethargy
  • Elevated fasting glucose
  • Vivid dreams
  • Carpal tunnel symptoms

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other growth hormone compounds the library lists it for
EffectAlso listed for (of 13)
Increased appetite1: GHRP-2
Water retention9: Ipamorelin, CJC-1295 with DAC, CJC-1295 no DAC, Sermorelin and 5 more
LethargyNone: listed for MK-677 alone
Elevated fasting glucoseNone: listed for MK-677 alone
Vivid dreamsNone: listed for MK-677 alone
Carpal tunnel symptoms1: CJC-1295 with DAC
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track MK-677 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which MK-677 side effects the growth hormone group shares

Across the 14 growth hormone compounds in the library, the effects listed most often are water retention (10 of 14), headache (5 of 14), injection site reaction (5 of 14) and fatigue (4 of 14). MK-677 shares 3 of its 6 listed effects with at least one other growth hormone compound; lethargy, elevated fasting glucose and vivid dreams are listed for MK-677 alone.

Where the MK-677 reports come from

The library rates the evidence on MK-677 as moderate: animal studies plus some human data.

Of the library’s 5 research notes on MK-677, 3 rest on randomized trials and 2 on community reports.

Our 8 study pages on MK-677: 6 randomized trials and 2 clinical trials.

So MK-677 has controlled trials in people to set its listed effects against.

What our MK-677 study pages report on safety

MK-677 raised IGF-1 but not most function after hip fracture

Randomized trial, human, 2011: In elderly patients after hip fracture, MK-677 raised IGF-1 without improving most measures of function, and a heart failure safety signal ended the trial early.

MK-677: fat-free mass rose 1.1 kg vs -0.5 kg on placebo at 1 year

Randomized trial, human, 2008: Growth hormone and insulin-like growth factor I (IGF-I) levels rose into the range of healthy young adults, with no serious side effects. The most common side effects were a rise in appetite that faded within a few months and short-lived, mild swelling of the lower legs and muscle pain, and the gain in fat-free mass did not translate into changes in strength or function.

MK-677 plus alendronate: 4.2% femoral neck BMD gain vs 2.5% alone

Randomized trial, human, 2001: The extra bone density gain showed up at only one of four sites measured, and people taking MK-677 had side effects linked to higher growth hormone, though few quit because of them. In older women with osteoporosis, MK-677 raised IGF-1 and bone turnover markers, but adding it to alendronate improved bone density only at the femoral neck, which the authors weighed against growth hormone side effects.

MK-677 reversed diet-driven nitrogen loss in 8 healthy adults

Randomized trial, human, 1998: IGF-I, a growth-related hormone, averaged 264 ng/mL on MK-677 vs 188 ng/mL on placebo, and IGF binding protein-3 was 3273 vs 2604 ng/mL; peak GH was 55.9 micrograms/L after the first dose and 22.6 micrograms/L after a week, cortisol and prolactin responses were not significantly higher than on placebo, and the drug was generally well tolerated.

MK-677: IGF-I rose 52% at 10 mg and 79% at 50 mg in GH-deficient men

Randomized trial, human, 1997: MK-677 was generally well tolerated with no significant change in cortisol, prolactin or thyroid hormones, but fasting and after-meal insulin and after-meal glucose went up significantly.

Questions people ask

What are the side effects of MK-677?

The side effects most commonly reported for MK-677 are increased appetite, water retention and lethargy, among 6 the library lists; the library’s evidence on it includes controlled trials in people.

Do MK-677’s side effects come from human studies?

The library rates the evidence on MK-677 as moderate, and the library’s evidence on it includes controlled trials in people.

Which MK-677 side effects are its own?

Among the growth hormone compounds, the library lists lethargy, elevated fasting glucose and vivid dreams for MK-677 alone.

More on MK-677

Track it in the app

PepVault for iPhone

Track MK-677 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo